Zhejiang Hisoar Pharmaceutical Co., Ltd. (SHE:002099)

SHE:002099 Revenue

Zhejiang Hisoar Pharmaceutical had revenue of 513.82M CNY in the quarter ending September 30, 2026, with 16.40% growth. This brings the company's total for the last twelve months to 2.03B, up 9.15% year-over-year. In the year 2025, Zhejiang Hisoar Pharmaceutical had annual revenue of 1.86B, down -4.01%. That makes Zhejiang Hisoar Pharmaceutical the 14,436th largest company in the world by revenue and 2,581st in China.

• Revenue (ttm): 2.03B
• Revenue Growth: +9.15%
• P/S Ratio: 4.39
• Revenue / Employee: 742.23K
• Employees: 2,736
• Market Cap: 9.14B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical Industry 1.31B 68.5%
• Dye Industry 572.76M 30.1%
• Others 27.66M 1.5%

By Geography

Chart

• Foreign 1.01B 54.5%
• China 846.36M 45.5%

Fiscal year ended Dec 31, 2025 See the full SHE:002099 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.86B	-77.77M	-4.01%
Dec 31, 2024	1.94B	-233.42M	-10.75%
Dec 31, 2023	2.17B	-532.26M	-19.68%
Jan 1, 2023	2.70B	219.32M	8.83%
Jan 1, 2022	2.48B	13.44M	0.54%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error